Loading...
NPI 1801834676 · Elmhurst, IL · Retina Specialist (Ophthalmology) Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Aaron Weinberg is a retina specialist (ophthalmology) physician provider located in Elmhurst, Illinois. This profile covers 17 Medicare and 6 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Aaron Weinberg |
| Address | 133 E Brush Hill Rd Ste 300 |
| City | Elmhurst |
| State | IL |
| ZIP | 60126 |
| Taxonomy | Retina Specialist (Ophthalmology) Physician |
| NPI Enumerated | June 3, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $3.3M |
| Medicaid | $1.2M |
This provider is operating as a retina-focused ophthalmology practice: the billing mix is dominated by intravitreal pharmacologic therapy (J0178, J9035, 67028) together with high-volume retinal imaging (92134), which is consistent with a medical retina practice that emphasizes repeated injections and imaging follow-up rather than primary comprehensive eye care. J0178 (aflibercept) is the single largest activity line by revenue across both payers, and E/M codes and major surgical retina codes appear only as small shares of total revenue.
Medicare revenue is heavily concentrated in a very small number of services: the top 3 Medicare codes account for 93.0% of the provider's total Medicare revenue, with J0178 alone representing $2.8M (84.3% of Medicare revenue). That concentration indicates the provider’s Medicare financial performance is largely dependent on intravitreal injection therapy and associated imaging.
Medicaid revenue is even more concentrated: the top 3 Medicaid codes account for 97.7% of this provider's Medicaid revenue, led by J0178 at $803.3K (68.7% of Medicaid revenue) and 67028 at $298.1K (25.5% of Medicaid revenue). The Medicaid payer mix shows the same service focus as Medicare but with an even larger share captured by the injection codes.
Payer scale and mix are skewed toward Medicare in absolute dollars: lifetime Medicare revenue is $3.3M versus $1.2M in Medicaid, so Medicare is the larger source of public-payer revenue for this provider. Both payers show the same dominant services, so clinical operations appear to be unified across payer lines rather than split into distinct Medicaid- or Medicare-specific service offerings.
The provider is a national and procedure-level outlier on key retina measures: for Medicare J0178 ranks #69 of 3204 nationally (98th percentile) and 92134 ranks #480 of 26868 providers nationally (98th percentile; described in the source as an "extreme outlier"). These ranks and percentiles, described in the file as "notably above typical national volume" and "extreme outlier," indicate the provider has materially higher throughput for aflibercept injections and retinal OCT imaging than most peers.
In-state competitive standing on Medicaid is substantial but not dominant: for Medicaid J0178 the provider ranks #13 of 45 in-state (73th percentile; typical, unremarkable volume for this code) and for 67028 ranks #28 of 120 in-state (77th percentile). Those positions show the provider is a meaningful regional participant in intravitreal injections but not the clear market leader statewide.
Operational and reimbursement nuances are visible between payers: the average paid per claim for J0178 is $691 on Medicare (4K claims) versus $1890 on Medicaid (425 claims), showing a large difference in per-claim payment levels and volume mix between payers for the same high-value drug code. This suggests that changes in payer pricing or drug mix could materially affect revenue per encounter.
Tenure and practice stability are evident: the NPI was enumerated on 2006-06-03 (~20 years ago), indicating a long-established practice that has generated sustained Medicare and Medicaid billing patterns centered on intravitreal therapy and retinal imaging. Historical presence combined with high percentile ranks on key injection and imaging codes suggests an established clinical throughput model rather than a recently scaled operation.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
17 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 3,990 | $690 | $2.8M |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 1,990 | $100 | $197.3K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 2,820 | $30 | $87.4K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 600 | $80 | $50.1K |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 290 | $160 | $45.6K |
| J9035 | Injection, bevacizumab, 10 mg | 610 | $50 | $32.8K |
| 92012 | For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any… | 490 | $70 | $32.1K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 150 | $120 | $17.6K |
| 67108 | The provider repairs a detached retina using heat produced by a laser beam or by freezing the tissues. He may attach a scleral buckle to simplify the passage of fluid through and behind the retina or… | 10 | $930 | $13K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 190 | $60 | $11.6K |
Showing 1–10 of 17
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 17 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
17 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 3 | 140 | 700 | $690 | $688.4K |
| 67028 | 18 | 190 | 400 | $90 | $64.4K |
| J7312 | 10 | 30 | 240 | $160 | $45.1K |
| 92014 | 215 | 1,420 | 130 | $80 | $24.7K |
| J9035 | 20 | 130 | 140 | $60 | $24.6K |
| 67042 | 47 | 50 | 20 | $870 | $21.8K |
| 67108 | 18 | 30 | 20 | $880 | $17.6K |
| 92012 | 77 | 670 | 100 | $60 | $12.4K |
| 92134 | 24 | 1,080 | 80 | $30 | $9K |
| 99213 | 3,897 | 17,390 | 70 | $60 | $8.8K |
Showing 1–10 of 17
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
6 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 430 | $1,890 | $803.3K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 1,840 | $160 | $298.1K |
| J9035 | Injection, bevacizumab, 10 mg | 750 | $60 | $41.3K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 2,070 | $10 | $26.9K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 10 | $20 | $290 |
| 92012 | For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any… | 10 | $20 | $290 |
How this provider's Medicaid billing volume and revenue compare to other Illinois providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Illinois median
6 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 13 | 50 | 200 | $1,100 | $391.2K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 28 | 120 | 540 | $160 | $166.3K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 1,165 | 1,230 | 450 | $40 | $54.1K |
| J9035 | Injection, bevacizumab, 10 mg | 24 | 80 | 290 | $60 | $43.4K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 58 | 250 | 510 | $20 | $20.1K |
| 92012 | For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any… | 644 | 670 | 230 | $30 | $16K |
Other providers in the same ZIP code as Aaron Weinberg, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Superior Air-ground Ambulance Service, Inc | IL | Land Ambulance | $16.1M | $90.5M |
| Shield - Denver Health Care Center, Inc. | IL | Parenteral & Enteral Nutrition Supplies (DME) | $0 | $100.7M |
| Rehabtech Supply, LLC | IL | Durable Medical Equipment & Medical Supplies | $0 | $89M |
| Home Medical Express Inc. | IL | Oxygen Equipment & Supplies (DME) | $0 | $22M |
| Trilab, LLC | IL | Clinical Medical Laboratory | $718K | $19.3M |
| Total Spectrum, LLC | IL | Behavior Analyst | $0 | $8.5M |
| Alvaro Candel | IL | Anatomic Pathology & Clinical Pathology Physician | $61.8K | $6.4M |
| Saad Ahmad | IL | Ophthalmology Physician | $3.3M | $2.4M |
| Mohamed Adenwalla | IL | Ophthalmology Physician | $2.3M | $2.4M |
| Kevin Patel | IL | Ophthalmology Physician | $2.3M | $589K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.